ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,136Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 487

$420K Total Retail Price of All Prescriptions

Rank: 70 out of 487

289 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 289 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 289 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,355 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
HYDROCODONE-ACETAMINOPHEN 342 170 S3 1 3
LEVOTHYROXINE SODIUM 252 224 2 1
OMEPRAZOLE 245 221 3 2
SIMVASTATIN 238 219 4 4
CITALOPRAM HBR 196 172 5 12
AMLODIPINE BESYLATE 182 163 6 6
LISINOPRIL 167 124 7 5
POTASSIUM CHLORIDE 162 146 8 10
WARFARIN SODIUM 155 145 9 11
FUROSEMIDE 136 120 10 7
GABAPENTIN 136 78 10 13
SPIRONOLACTONE 121 115 12 43
DONEPEZIL HCL 118 112 13 38
PREDNISONE 112 96 14 37
FLUOXETINE HCL 110 84 15 28
METOPROLOL SUCCINATE 109 88 16 15
TRAZODONE HCL 105 70 17 22
LOSARTAN POTASSIUM 104 93 18 16
HYDROCHLOROTHIAZIDE 104 86 18 9
METFORMIN HCL 92 74 20 8
CRESTOR 83 83 21 42
ATORVASTATIN CALCIUM 83 77 21 18
BENAZEPRIL HCL 79 72 23 67
ATENOLOL 79 49 23 23
METHOCARBAMOL 77 12 R 25 118
METOPROLOL TARTRATE 75 75 26 17
SERTRALINE HCL 71 35 27 21
TAMSULOSIN HCL 71 70 27 25
GLIMEPIRIDE 71 61 27 35
ENALAPRIL MALEATE 71 64 27 80
SPIRIVA 69 54 31 48
MORPHINE SULFATE ER 67 34 S2 32 54
BUPROPION HCL SR 66 37 33 139
ALLOPURINOL 66 63 33 29
TRIAMTERENE-HCTZ 61 50 35 49
ALENDRONATE SODIUM 60 60 36 27
ZOLPIDEM TARTRATE 60 33 36 14
JANUVIA 59 40 38 99
CLOPIDOGREL 58 44 39 91
TRAMADOL HCL 58 35 39 19
LANTUS 54 48 41 44
NAMENDA 53 53 42 53
MICARDIS 53 53 42 201
PROAIR HFA 51 48 44 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.